Humber and North Yorkshire Cancer Alliance is pleased to announce the appointment of Kartikae Grover as its new Clinical Director.
Kartikae will play a key role in bringing together the different organisations which provide cancer services in Humber and North Yorkshire to work collectively to improve cancer outcomes for the people living in the region.
Kartikae, Associate Chief Medical Officer (Quality and Safety) and a Consultant Oncoplastic Breast Surgeon at Hull University Teaching Hospitals NHS Trust, succeeds Dr Stuart Baugh who has served as the Cancer Alliance’s Clinical Director for several years.
He will officially join the Cancer Alliance role in June and will combine this role while continuing to work in his various positions at Hull University Teaching Hospitals NHS Trust.
Kartikae joined Hull University Teaching Hospitals NHS Trust in 2011. He has played a pivotal role in establishing the trust’s health inequalities steering group, and has held a number of senior positions, including Clinical Information Officer, Governance Lead and Clinical Lead of the breast service. Kartikae was also chair of the Humber and Yorkshire Coast Cancer Network’s Breast Clinical Experts Group between 2012 and 2014.
Commenting on Kartikae’s appointment, Lucy Turner, Humber and North Yorkshire Cancer Alliance Managing Director, said: “I am delighted to announce the appointment of Kartikae as our new Clinical Director. Kartikae is passionate about cancer services, improving patient experience and outcomes and recognises the benefits of innovation and collaborative working.
“I want to place on record my sincere thanks to Stuart Baugh for his contribution to the Cancer Alliance over the last five years. He has played a significant role in driving and delivering key programmes such as the NHS Targeted Lung Health Checks in Humber and North Yorkshire.”
Kartikae said: “I am honoured to be joining the Cancer Alliance as Clinical Director. I am looking forward to commencing in this leadership role very soon and working with partners across the region to further develop cancer services which deliver the best possible treatments and care for patients.”
